TET enzymatic oxidation of 5-methylcytosine, 5-hydroxymethylcytosine and 5-formylcytosine

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 764-765, Issue , 2014, Pages 18-35

  Cadet, Jean ^a,b   Wagner, J Richard ^b  

^a CEA GRENOBLE   (France)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Biological role; DNA glycosylase mediated repair; Epigenetic marks; Hydrolytic and enzymatic deamination; Radical oxidation reactions

Indexed keywords

5 FORMYLCYTOSINE; 5 HYDROXYMETHYLCYTOSINE; 5 METHYLCYTOSINE; CELL DNA; CELL ENZYME; CYTOSINE DERIVATIVE; DNA POLYMERASE; HYDROXYL RADICAL; NUCLEOSIDE; OLIGONUCLEOTIDE; PHOSPHORUS 32; RNA POLYMERASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER TISSUE; CAPILLARY ELECTROPHORESIS; DEAMINATION; DEMETHYLATION; DERIVATIZATION; DNA REPAIR; EXCISION REPAIR; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; MUTAGENESIS; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RADICAL REACTION; TANDEM MASS SPECTROMETRY; THIN LAYER CHROMATOGRAPHY;

BIOLOGICAL ROLE; DNA GLYCOSYLASE-MEDIATED REPAIR; EPIGENETIC MARKS; HYDROLYTIC AND ENZYMATIC DEAMINATION; RADICAL OXIDATION REACTIONS;

5-METHYLCYTOSINE; ANIMALS; CYTOSINE; DIOXYGENASES; DNA; DNA METHYLATION; DNA REPAIR; HUMANS; MODELS, BIOLOGICAL; MUTAGENESIS; NEOPLASMS; OXIDATION-REDUCTION;

EID: 84898770107     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2013.09.001     Document Type: Article

References (237)

1. Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr. Opin. Genet. Dev. 2005, 15:490-495.
2. Suzuki M.M., Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 2008, 9:465-476.
3. T. Suganuma, J.L. Workman, Signals and combinatorial functions of histone modifications, 2011, pp. 473-499.
4. Fu Y., He C. Nucleic acid modifications with epigenetic significance. Curr. Opin. Chem. Biol. 2012, 16:516-524.
5. Liutkeviit Z., Lukinaviius G., Maseviius V., Daujotyt D., Klimaauskas S. Cytosine-5-methyltransferases add aldehydes to DNA. Nat. Chem. Biol. 2009, 5:400-402.
6. Hobartner C. Enzymatic labeling of 5-hydroxymethylcytosine in DNA. Angew. Chem. Int. Ed. 2011, 50:4268-4270.
7. Bestor T.H. The DNA methyltransferases of mammals. Hum. Mol. Genet. 2000, 9:2395-2402.
8. Law J.A., Jacobsen S.E. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat. Rev. Genet. 2010, 11:204-220.
9. Auclair G., Weber M. Mechanisms of DNA methylation and demethylation in mammals. Biochimie 2012, 94:2202-2211.
10. Smith Z.D., Chan M.M., Mikkelsen T.S., Gu H., Gnirke A., Regev A., Meissner A. A unique regulatory phase of DNA methylation in the early mammalian embryo. Nature 2012, 484:339-344.
11. Hergersberg M. Biological aspects of cytosine methylation in eukaryotic cells. Experientia 1991, 47:1171-1185.
12. Carell T., Brandmayr C., Hienzsch A., Müller M., Pearson D., Reiter V., Thoma I., Thumbs P., Wagner M. Structure and function of noncanonical nucleobases. Angew. Chem. Int. Ed. 2012, 51:7110-7131.
13. Hotchkiss R.D. The quantitative separation of purines, pyrimidines, and nucleosides by paper chromatography. J. Biol. Chem. 1948, 175:315-332.
14. Wyatt G.R. Recognition and estimation of 5-methylcytosine in nucleic acids. Biochem. J. 1951, 48:581-584.
15. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007, 447:425-432.
16. Tsukada Y.I. Hydroxylation mediates chromatin demethylation. J. Biochem. 2012, 151:229-246.
17. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat. Rev. Genet. 2002, 3:662-673.
18. Jaenisch R., Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 2003, 33:245-254.
19. Robertson K.D. DNA methylation and human disease. Nat. Rev. Genet. 2005, 6:597-610.
20. Klose R.J., Bird A.P. Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 2006, 31:89-97.
21. Jones P.A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 2012, 13:484-492.
22. Wagner J.R., Cadet J. Oxidation reactions of cytosine DNA components by hydroxyl radical and one-electron oxidants in aerated aqueous solutions. Acc. Chem. Res. 2010, 43:564-571.
23. Wyatt G.R., Cohen S.S. The bases of the nucleic acids of some bacterial and animal viruses: the occurrence of 5-hydroxymethylcytosine. Biochem. J. 1953, 55:774-782.
24. Wyatt G.R., Cohen S.S. A new pyrimidine base from bacteriophage nucleic acids. Nature 1952, 170:1072-1073.
25. Penn N.W., Suwalski R., O'Riley C., Bojanowski K., Yura R. The presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid. Biochem. J. 1972, 126:781-790.
26. Kothari R.M., Shankar V. 5 Methylcytosine content in the vertebrate deoxyribonucleic acids: species specificity. J. Mol. Evol. 1976, 7:325-329.
27. Tahiliani M., Koh K.P., Shen Y.H., Pastor W.A., Bandukwala H., Brudno Y., Agarwal S., Iyer L.M., Liu D.R., Aravind L., Rao A. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935.
28. Kriaucionis S., Heintz N. The nuclear DNA base 5-hydroxymethylcytosine Is present in Purkinje neurons and the brain. Science 2009, 324:929-930.
29. Munzel M., Globisch D., Bruckl T., Wagner M., Welzmiller V., Michalakis S., Muller M., Biel M., Carell T. Quantification of the sixth DNA base hydroxymethylcytosine in the brain. Angew. Chem. Int. Ed. 2010, 49:5375-5377.
30. Globisch D., Münzel M., Müller M., Michalakis S., Wagner M., Koch S., Brückl T., Biel M., Carell T. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS One 2010, 5:e15367.
31. Song C.X., He C. The hunt for 5-hydroxymethylcytosine: the sixth base. Epigenomics 2011, 3:521-523.
32. Ponnaluri V.K.C., Maciejewski J.P., Mukherji M. A mechanistic overview of TET-mediated 5-methylcytosine oxidation. Biochem. Biophys. Res. Commun. 2013, 436:115-120.
33. Zhao H., Chen T. Tet family of 5-methylcytosine dioxygenases in mammalian development. J. Hum. Genet. 2013, 58:421-427.
34. Shen L., Zhang Y. 5-Hydroxymethylcytosine: generation, fate, and genomic distribution. Curr. Opin. Cell Biol. 2013, 25:289-296.
35. Hackett J.A., Zylicz J.J., Surani M.A. Parallel mechanisms of epigenetic reprogramming in the germline. Trends Genet. 2012, 28:164-174.
36. Branco M.R., Ficz G., Reik W. Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat. Rev. Genet. 2012, 13:7-13.
37. S.R.M. Kinney, S. Pradhan, Ten eleven translocation enzymes and 5-hydroxymethylation in mammalian development and cancer, in: A.R. Karpf (Ed.) 2013, pp. 57-79.
38. Matarese F., Carrillo-de Santa Pau E., Stunnenberg H.G. 5-Hydroxymethylcytosine: a new kid on the epigenetic block?. Mol. Syst. Biol. 2011, 7:562.
39. Jia G., Fu Y., He C. Reversible RNA adenosine methylation in biological regulation. Trends Genet. 2013, 29:108-115.
40. Iyer L.M., Tahiliani M., Rao A., Aravind L. Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids. Cell Cycle 2009, 8:1698-1710.
41. Jia G., Fu Y., Zhao X., Dai Q., Zheng G., Yang Y., Yi C., Lindahl T., Pan T., Yang Y.G., He C. N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat. Chem. Biol. 2011, 7:885-887.
42. Duncan T., Trewick S.C., Koivisto P., Bates P.A., Lindahl T., Sedgwick B. Reversal of DNA alkylation damage by two human dioxygenases. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:16660-16665.
43. Aas P.A., Otterlei M., Falnes P.Ø., Vågbø C.B., Skorpen F., Akbari M., Sundheim O., Bjørås M., Slupphaug G., Seeberg E., Krokan H.E. Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA. Nature 2003, 421:859-863.
44. Sedgwick B., Bates P.A., Paik J., Jacobs S.C., Lindahl T. Repair of alkylated DNA: recent advances. DNA Repair 2007, 6:429-442.
45. Ramsahoye B.H. Nearest-neighbor analysis. Methods Mol. Biol. (Clifton, N.J.) 2002, 200:9-15.
46. Ito S., Shen L., Dai Q., Wu S.C., Collins L.B., Swenberg J.A., He C., Zhang Y. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011, 333:1300-1303.
47. He Y.F., Li B.Z., Li Z., Liu P., Wang Y., Tang Q., Ding J., Jia Y., Chen Z., Li N., Sun Y., Li X., Dai Q., Song C.X., Zhang K., He C., Xu G.L. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 2011, 333:1303-1307.
48. Szwagierczak A., Bultmann S., Schmidt C.S., Spada F., Leonhardt H. Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res. 2010, 38:e181.
49. Terragni J., Bitinaite J., Zheng Y., Pradhan S. Biochemical characterization of recombinant β-glucosyltransferase and analysis of global 5-hydroxymethylcytosine in unique genomes. Biochemistry 2012, 51:1009-1019.
50. Cadet J., Wagner J.R. DNA base damage by reactive oxygen species, oxidizing agents, and UV radiation. Cold Springs Harb. Perspect. Biol. 2013, 5:a012559.
51. Kriukiene E., Liutkevičiute Z., Klimašauskas S. 5-Hydroxymethylcytosine - the elusive epigenetic mark in mammalian DNA. Chem. Soc. Rev. 2012, 41:6916-6930.
52. Song C.X., Szulwach K.E., Fu Y., Dai Q., Yi C., Li X., Li Y., Chen C.H., Zhang W., Jian X., Wang J., Zhang L., Looney T.J., Zhang B., Godley L.A., Hicks L.M., Lahn B.T., Jin P., He C. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat. Biotechnol. 2011, 29:68-75.
53. Song C.X., He C. Bioorthogonal labeling of 5-hydroxymethylcytosine in genomic DNA and diazirine-based DNA Photo-cross-linking probes. Acc. Chem. Res. 2011, 44:709-717.
54. Liutkeviciute Z., Kriukiene E., Grigaityte I., Masevicius V., Klimasauskas S. Methyltransferase-directed derivatization of 5-hydroxymethylcytosine in DNA. Angew. Chem. Int. Ed. 2011, 50:2090-2093.
55. Ito S., Dalessio A.C., Taranova O.V., Hong K., Sowers L.C., Zhang Y. Role of tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010, 466:1129-1133.
56. Iqbal K., Jin S.G., Pfeifer G.P., Szabo P.E. Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:3642-3647.
57. Ficz G., Branco M.R., Seisenberger S., Santos F., Krueger F., Hore T.A., Marques C.J., Andrews S., Reik W. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 2011, 473:398-402.
58. Nestor C.E., Ottaviano R., Reddington J., Sproul D., Reinhardt D., Dunican D., Katz E., Dixon J.M., Harrison D.J., Meehan R.R. Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res. 2012, 22:467-477.
59. Li W., Liu M. Distribution of 5-hydroxymethylcytosine in different human tissues. J. Nucleic Acids 2011, 2011:870726.
60. Williams K., Christensen J., Pedersen M.T., Johansen J.V., Cloos P.A.C., Rappsilber J., Helin K. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2011, 473:343-349.
61. Acevedo L.G., Sanz A., Jelinek M.A. Novel DNA binding domain-based assays for detection of methylated and nonmethylated DNA. Epigenomics 2011, 3:93-101.
62. Cadet J., Douki T., Ravanat J.L., Wagner J.R. Measurement of oxidatively generated base damage to nucleic acids in cells: facts and artifacts. Bioanal. Rev. 2012, 4:55-74.
63. Ko M., Huang Y., Jankowska A.M., Pape U.J., Tahiliani M., Bandukwala H.S., An J., Lamperti E.D., Koh K.P., Ganetzky R., Liu X.S., Aravind L., Agarwal S., Maciejewski J.P., Rao A. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 2010, 468:839-843.
64. Jin S.G., Kadam S., Pfeifer G.P. Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res. 2010, 38:e125.
65. Wu H., D'Alessio A.C., Ito S., Wang Z., Cui K., Zhao K., Sun Y.E., Zhang Y. Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev. 2011, 25:679-684.
66. Ruzov A., Tsenkina Y., Serio A., Dudnakova T., Fletcher J., Bai Y., Chebotareva T., Pells S., Hannoun Z., Sullivan G., Chandran S., Hay D.C., Bradley M., Wilmut I., De Sousa P. Lineage-specific distribution of high levels of genomic 5-hydroxymethylcytosine in mammalian development. Cell Res. 2011, 21:1332-1342.
67. Inoue A., Matoba S., Zhang Y. Transcriptional activation of transposable elements in mouse zygotes is independent of Tet3-mediated 5-methylcytosine oxidation. Cell Res. 2012, 22:1640-1649.
68. Gu T.P., Guo F., Yang H., Wu H.P., Xu G.F., Liu W., Xie Z.G., Shi L., He X., Jin S.G., Iqbal K., Shi Y.G., Deng Z., Szabó P.E., Pfeifer G.P., Li J., Xu G.L. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature 2011, 477:606-612.
69. Morgan G.T., Jones P., Bellini M. Association of modified cytosines and the methylated DNA-binding protein MeCP2 with distinctive structural domains of lampbrush chromatin. Chromosome Res. 2012, 20:925-942.
70. Hackett J.A., Sengupta R., Zylicz J.J., Murakami K., Lee C., Down T.A., Surani M.A. Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. Science 2013, 339:448-452.
71. Yamaguchi S., Hong K., Liu R., Inoue A., Shen L., Zhang K., Zhang Y. Dynamics of 5-methylcytosine and 5-hydroxymethylcytosine during germ cell reprogramming. Cell Res. 2013, 23:329-339.
72. Vincent J., Huang Y., Chen P.Y., Feng S., Calvopiña J., Nee K., Lee S., Le T., Yoon A., Faull K., Fan G., Rao A., Jacobsen S., Pellegrini M., Clark A. Stage-specific roles for Tet1 and Tet2 in DNA demethylation in primordial germ cells. Cell Stem Cell 2013, 12:470-478.
73. Mellén M., Ayata P., Dewell S., Kriaucionis S., Heintz N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 2012, 151:1417-1430.
74. Hahn M., Qiu R., Wu X., Li A., Zhang H., Wang J., Jui J., Jin S.G., Jiang Y., Pfeifer G., Lu Q. Dynamics of 5-hydroxymethylcytosine and chromatin marks in mammalian neurogenesis. Cell Rep. 2013, 3:291-300.
75. Lian C.G., Xu Y., Ceol C., Wu F., Larson A., Dresser K., Xu W., Tan L., Hu Y., Zhan Q., Lee C.W., Hu D., Lian B.Q., Kleffel S., Yang Y., Neiswender J., Khorasani A.J., Fang R., Lezcano C., Duncan L.M., Scolyer R.A., Thompson J.F., Kakavand H., Houvras Y., Zon L.I., Mihm M.C., Kaiser U.B., Schatton T., Woda B.A., Murphy G.F., Shi Y.G. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 2012, 150:1135-1146.
76. Orr B.A., Haffner M.C., Nelson W.G., Yegnasubramanian S., Eberhart C.G. Decreased 5-Hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. PLoS One 2012, 7:e41036.
77. Waha A., Müller T., Gessi M., Isselstein L.J., Luxen D., Freihoff D., Freihoff J., Becker A., Simon M., Hammes J., Denkhaus D., Zur Mühlen A., Pietsch T. Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas. Am. J. Pathol. 2012, 181:675-683.
78. Haffner M.C., Chaux A., Meeker A.K., Esopi D.M., Gerber J., Pellakuru L.G., Toubaji A., Argani P., Iacobuzio-Donahue C., Nelson W.G., Netto G.J., De Marzo A.M., Yegnasubramanian S. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget 2011, 2:627-637.
79. Inoue A., Shen L., Dai Q., He C., Zhang Y. Generation and replication-dependent dilution of 5fC and 5caC during mouse preimplantation development. Cell Res. 2011, 21:1670-1676.
80. Raiber E.A., Beraldi D., Ficz G., Burgess H., Branco M.R., Murat P., Oxley D., Booth M.J., Reik W., Balasubramanian S. Genome-wide distribution of 5-formylcytosine in ES cells is associated with transcription and depends on thymine DNA glycosylase. Genome Biol. 2012, 13:R69.
81. Alioui A., Wheldon L.M., Abakir A., Ferjentsik Z., Johnson A.D., Ruzov A. 5-Carboxylcytosine is localized to euchromatic regions in the nuclei of follicular cells in axolotl ovary. Nucleus 2012, 3:565-569.
82. Cadet J., Poulsen H. Measurement of oxidatively generated base damage in cellular DNA and urine. Free Radic. Biol. Med. 2010, 48:1457-1459.
83. Cadet J., Mouret S., Ravanat J.L., Douki T. Photoinduced damage to cellular DNA: direct and photosensitized reactions. Photochem. Photobiol. 2012, 88:1048-1065.
84. Cadet J., Douki T., Ravanat J.L. Oxidatively generated base damage to cellular DNA. Free Radic. Biol. Med. 2010, 49:9-21.
85. Pfaffeneder T., Hackner B., Truß M., Münzel M., Müller M., Deiml C.A., Hagemeier C., Carell T. The discovery of 5-formylcytosine in embryonic stem cell DNA. Angew. Chem. Int. Ed. 2011, 50:7008-7012.
86. Le T., Kim K.P., Fan G., Faull K.F. A sensitive mass spectrometry method for simultaneous quantification of DNA methylation and hydroxymethylation levels in biological samples. Anal. Biochem. 2011, 412:203-209.
87. L. Shen, Y. Zhang, Enzymatic analysis of tet proteins: Key enzymes in the metabolism of DNA methylation, 2012, pp. 93-105.
88. Liu S., Wang J., Siu Y., Guerrero C., Zeng Y., Mitra D., Brooks P.J., Fisher D.E., Song H., Wang Y. Quantitative assessment of Tet-induced oxidation products of 5-methylcytosine in cellular and tissue DNA. Nucleic Acids Res. 2013, 41:6421-6429.
89. Pronier E., Almire C., Mokrani H., Vasanthakumar A., Simon A., Da Costa Reis Monte Mor B., Massé A., Le Couédic J.P., Pendino F., Carbonne B., Larghero J., Ravanat J.L., Casadevall N., Bernard O.A., Droin N., Solary E., Godley L.A., Vainchenker W., Plo I., Delhommeau F. Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors. Blood 2011, 118:2551-2555.
90. Kraus T.F.J., Globisch D., Wagner M., Eigenbrod S., Widmann D., Münzel M., Müller M., Pfaffeneder T., Hackner B., Feiden W., Schüller U., Carell T., Kretzschmar H.A. Low values of 5-hydroxymethylcytosine (5hmC), the sixth base, are associated with anaplasia in human brain tumors. Int. J. Cancer 2012, 131:1577-1590.
91. Spruijt C., Gnerlich F., Smits A., Pfaffeneder T., Jansen P.T.C., Bauer C., Münzel M., Wagner M., Müller M., Khan F., Eberl H., Mensinga A., Brinkman A., Lephikov K., Müller U., Walter J., Boelens R., van Ingen H., Leonhardt H., Carell T., Vermeulen M. Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 2013, 1146-1159.
92. Gan H., Wen L., Liao X., Lin T., Ma J., Liu J., Song C.-X., Wang M., He C., Han C., Tan F. Dynamics of 5-hydroxymethylcytosine during mouse spermatogenesis. Nat. Commun. 2013, 4:1995.
93. Tang Y., Chu J.M., Huang W., Xiong J., Xing X.W., Zhou X., Feng Y.Q., Yuan B.F. Hydrophilic material for the selective enrichment of 5- hydroxymethylcytosine and its LC-MS/MS detection. Anal. Chem. 2013, 85:6129-6135.
94. Chen M.L., Shen F., Huang W., Qi J.H., Wang Y., Feng Y.Q., Liu S.M., Yuan B.F. Quantification of 5-methylcytosine and 5-hydroxymethylcytosine in genomic DNA from hepatocellular carcinoma tissues by capillary hydrophilic-interaction liquid chromatography/quadrupole TOF mass spectrometry. Clin. Chem. 2013, 59:824-832.
95. Krais A.M., Park Y.J., Plass C., Schmeiser H.H. Determination of genomic 5-hydroxymethyl-2'-deoxycytidine in human DNA by capillary electrophoresis with laser-induced fluorescence. Epigenetics 2011, 6:560-565.
96. Grønbæk K., Müller-Tidow C., Perini G., Lehmann S., Treppendahl M.B., Mills K., Plass C., Schlegelberger B. A critical appraisal of tools available for monitoring epigenetic changes in clinical samples from patients with myeloid malignancies. Haematologica 2012, 97:1380-1388.
97. Ndlovu T.N., Denis H., Fuks F. Exposing the DNA methylome iceberg. Trends Biochem. Sci. 2011, 36:381-387.
98. Zilberman D., Henikoff S. Genome-wide analysis of DNA methylation patterns. Development 2007, 134:3959-3965.
99. Ku C.S., Naidoo N., Wu M., Soong R. Studying the epigenome using next generation sequencing. J. Med. Genet. 2011, 48:721-730.
100. Song C.X., Yi C., He C. Mapping recently identified nucleotide variants in the genome and transcriptome. Nat. Biotechnol. 2012, 30:1107-1116.
101. R.P. Nagarajan, S.D., Fouse, R.J.A., Bell, J.F. Costello, Methods for cancer epigenome analysis, in: A.R. Karpf (Ed.), 2013, pp. 313-338.
102. Jin S.G., Wu X., Li A.X., Pfeifer G.P. Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Res. 2011, 39:5015-5024.
103. Pastor W.A., Pape U.J., Huang Y., Henderson H.R., Lister R., Ko M., McLoughlin E.M., Brudno Y., Mahapatra S., Kapranov P., Tahiliani M., Daley G.Q., Liu X.S., Ecker J.R., Milos P.M., Agarwal S., Rao A. Genome-widemapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 2011, 473:394-397.
104. Huang Y., Pastor W.A., Zepeda-Martínez J.A., Rao A. The anti-CMS technique for genome-wide mapping of 5-hydroxymethylcytosine. Nat. Protoc. 2012, 7:1897-1908.
105. Robertson A.B., Dahl J.A., Ougland R., Klungland A. Pull-down of 5-hydroxymethylcytosine DNA using JBP1-coated magnetic beads. Nat. Protoc. 2012, 7:340-350.
106. Robertson A.B., Dahl J.A., Vagbo C.B., Tripathi P., Krokan H.E., Klungland A. A novel method for the efficient and selective identification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res. 2011, 39:e55.
107. Sun Z., Terragni J., Borgaro J.G., Liu Y., Yu L., Guan S., Wang H., Sun D., Cheng X., Zhu Z., Pradhan S., Zheng Y. High-resolution enzymatic mapping of genomic 5-hydroxymethylcytosine in mouse embryonic stem cells. Cell Rep. 2013, 3:567-576.
108. Borgaro J.G., Zhu Z. Characterization of the 5-hydroxymethylcytosine-specific DNA restriction endonucleases. Nucleic Acids Res. 2013, 41:4198-4206.
109. Yu M., Hon G.C., Szulwach K.E., Song C.X., Zhang L., Kim A., Li X., Dai Q., Shen Y., Park B., Min J.H., Jin P., Ren B., He C. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell 2012, 149:1368-1380.
110. Booth M.J., Branco M.R., Ficz G., Oxley D., Krueger F., Reik W., Balasubramanian S. Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science 2012, 336:934-937.
111. Lu X., Song C.X., Szulwach K., Wang Z., Weidenbacher P., Jin P., He C. Chemical modification-assisted bisulfite sequencing (CAB-seq) for 5-carboxylcytosine detection in DNA. J. Am. Chem. Soc. 2013, 135:9315-9317.
112. Song C.X., Clark T.A., Lu X.Y., Kislyuk A., Dai Q., Turner S.W., He C., Korlach J. Sensitive and specific single-molecule sequencing of 5- hydroxymethylcytosine. Nat. Methods 2012, 9:75-77.
113. Szulwach K.E., Li X., Li Y., Song C.X., Wu H., Dai Q., Irier H., Upadhyay A.K., Gearing M., Levey A.I., Vasanthakumar A., Godley L.A., Chang Q., Cheng X., He C., Jin P. 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat. Neurosci. 2011, 14:1607-1616.
114. Szulwach K.E., Li X., Li Y., Song C.X., Han J.W., Kim S., Namburi S., Hermetz K., Kim J.J., Rudd M.K., Yoon Y.S., Ren B., He C., Jin P. Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells. PLoS Genet. 2011, 7:e1002154.
115. Pastor W.A., Huang Y., Henderson H.R., Agarwal S., Rao A. The GLIB technique for genome-wide mapping of 5-hydroxymethylcytosine. Nat. Protoc. 2012, 7:1909-1917.
116. Song C.X., Szulwach K.E., Dai Q., Fu Y., Mao S.Q., Lin L., Street C., Li Y., Poidevin M., Wu H., Gao J., Liu P., Li L., Xu G.L., Jin P., He C. Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell 2013, 153:678-691.
117. Li W.W., Gong L., Bayley H. Single-molecule detection of 5-hydroxymethylcytosine in DNA through chemical modification and nanopore analysis. Angew. Chem. Int. Ed. 2013, 52:4350-4355.
118. Tardy-Planechaud S., Fujimoto J., Lin S.S., Sowers L.C. Solid phase synthesis and restriction endonuclease cleavage of oligodeoxynucleotides containing 5-(hydroxymethyl)-cytosine. Nucleic Acids Res. 1997, 25:553-558.
119. Khare T., Pai S., Koncevicius K., Pal M., Kriukiene E., Liutkeviciute Z., Irimia M., Jia P., Ptak C., Xia M., Tice R., Tochigi M., Moréra S., Nazarians A., Belsham D., Wong A.H.C., Blencowe B.J., Wang S.C., Kapranov P., Kustra R., Labrie V., Klimasauskas S., Petronis A. 5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary. Nat. Struct. Mol. Biol. 2012, 19:1037-1044.
120. Williams K., Christensen J., Helin K. DNA methylation: TET proteins-guardians of CpG islands?. EMBO Rep. 2012, 13:28-35.
121. Dawlaty M.M., Breiling A., Le T., Raddatz G., Barrasa M.I., Cheng A.W., Gao Q., Powell B.E., Li Z., Xu M., Faull K.F., Lyko F., Jaenisch R. Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal Development. Dev. Cell 2013, 24:310-323.
122. Iqbal K., Jin S.G., Pfeifer G.P., Szabó P.E. Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:3642-3647.
123. Szabó P.E., Pfeifer G.P. H3K9me2 attracts PGC7 in the zygote to prevent Tet3-mediated oxidation of 5-methylcytosine. J. Mol. Cell Biol. 2012, 4:427-429.
124. Shock L.S., Thakkar P.V., Peterson E.J., Moran R.G., Taylor S.M. DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:3630-3635.
125. Loenarz C., Schofield C.J. Oxygenase catalyzed 5-methylcytosine hydroxylation. Chem. Biol. 2009, 16:580-583.
126. Wu S.C., Zhang Y. Active DNA demethylation: many roads lead to Rome. Nat. Rev. Mol. Cell Biol. 2010, 11:607-620.
127. Smiley J.A., Kundracik M., Landfried D.A., Barnes V.R., Axhemi A.A. Genes of the thymidine salvage pathway: thymine-7-hydroxylase from a Rhodotorula glutinis cDNA library and iso-orotate decarboxylase from Neurospora crassa. Biochim. Biophys. Acta 2005, 1723:256-264.
128. Simmons J.M., Müller T.A., Hausinger R.P. FeII/α-ketoglutarate hydroxylases involved in nucleobase, nucleoside, nucleotide, and chromatin metabolism. Dalton Trans. 2008, 5132-5142.
129. Neidigh J.W., Darwanto A., Williams A.A., Wall N.R., Sowers L.C. Cloning and characterization of Rhodotorula glutinis thymine hydroxylase. Chem. Res. Toxicol. 2009, 22:885-893.
130. Maiti A., Drohat A.C. Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: Potential implications for active demethylation of CpG sites. J. Biol. Chem. 2011, 286:35334-35338.
131. Tan L., Shi Y.G. Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development 2012, 139:1895-1902.
132. Yu Z., Genest P.A., ter Riet B., Sweeney K., DiPaolo C., Kieft R., Christodoulou E., Perrakis A., Simmons J.M., Hausinger R.P., van Luenen H.G.A.M., Rigden D.J., Sabatini R., Borst P. The protein that binds to DNA base J in trypanosomatids has features of a thymidine hydroxylase. Nucleic Acids Res. 2007, 35:2107-2115.
133. 2+/2-oxoglutarate-dependent dioxygenases regulating hydroxylation of thymidine residues in trypanosome DNA. J. Biol. Chem. 2012, 287:19886-19895.
134. Zhang H., Zhang X., Clark E., Mulcahey M., Huang S., Shi Y.G. TET1 is a DNA-binding protein that modulates DNA methylation and gene transcription via hydroxylation of 5-methylcytosine. Cell Res. 2010, 20:1390-1393.
135. Song J., Rechkoblit O., Bestor T.H., Patel D.J. Structure of DNMT1-DNA complex reveals a role for autoinhibition in maintenance DNA methylation. Science 2011, 331:1036-1040.
136. Xu C., Bian C., Lam R., Dong A., Min J. The structural basis for selective binding of non-methylated CpG islands by the CFP1 CXXC domain. Nat. Commun. 2011, 2:227.
137. Ko M., An J., Bandukwala H.S., Chavez L., Äijö T., Pastor W.A., Segal M.F., Li H., Koh K.P., Lähdesmäki H., Hogan P.G., Aravind L., Rao A. Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX. Nature 2013, 497:122-126.
138. McDonough M.A., Loenarz C., Chowdhury R., Clifton I.J., Schofield C.J. Structural studies on human 2-oxoglutarate dependent oxygenases. Curr. Opin. Struct. Biol. 2010, 20:659-672.
139. Loenarz C., Schofield C.J. Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases. Trends Biochem. Sci. 2011, 36:7-18.
140. Krebs C., Fujimori D.G., Walsh C.T., Bollinger J.M. Non-heme Fe(IV)-oxo intermediates. Acc. Chem. Res. 2007, 40:484-492.
141. Bugg T.D.H. Dioxygenase enzymes: catalytic mechanisms and chemical models. Tetrahedron 2003, 59:7075-7101.
142. Chung T.L., Brena R.M., Kolle G., Grimmond S.M., Berman B.P., Laird P.W., Pera M.F., Wolvetang E.J. Vitamin C promotes widespread yet specific DNA demethylation of the epigenome in human embryonic stem cells. Stem Cells 2010, 28:1848-1855.
143. Blaschke K., Ebata K.T., Karimi M.M., Zepeda-Martínez J.A., Goyal P., Mahapatra S., Tam A., Laird D.J., Hirst M., Rao A., Lorincz M.C., Ramalho-Santos M. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature 2013, 500:222-226.
144. Minor E.A., Court B.L., Young J.I., Wang G. Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine. J. Biol. Chem. 2013, 288:13669-13674.
145. Yin R., Mao S.Q., Zhao B., Chong Z., Yang Y. Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals. J. Am. Chem. Soc. 2013, 135:10396-10403.
146. Cadet J., Loft S., Olinski R., Evans M.D., Bialkowski K., Wagner J.R., Dedon P.C., Møller P., Greenberg M.M., Cooke M.S. Biologically relevant oxidants and terminology, classification and nomenclature of oxidatively generated damage to nucleobases and 2-deoxyribose in nucleic acids. Free Radic. Res. 2012, 46:367-381.
147. Lee Y.A., Yun B.H., Kim S.K., Margolin Y., Dedon P.C., Geacintov N.E., Shafirovich V. Mechanisms of oxidation of guanine in DNA by carbonate radical anion, a decomposition product of nitrosoperoxycarbonate. Chem. Eur. J. 2007, 13:4571-4581.
148. Cadet J., Ravanat J.L., TavernaPorro M., Menoni H., Angelov D. Oxidatively generated complex DNA damage: tandem and clustered lesions. Cancer Lett. 2012, 327:5-15.
149. Brem R., Karran P. Multiple forms of DNA damage caused by UVA photoactivation of DNA 6-thioguanine. Photochem. Photobiol. 2012, 88:5-13.
150. Masuda T., Shinohara H., Kondo M. Reactions of hydroxyl radicals with nucleic acid bases and the related compounds in gamma irradiated aqueous solution. J. Radiat. Res. 1975, 16:153-161.
151. von Sonntag C. Free-Radical-Induced DNA Damage and its Repair. A Chemical Perspective 2006, Springer-Verlag, Berlin-Heidelberg-NewYork.
152. .OH radical reactions with 5-methylcytosine. J. Phys. Chem. A 2007, 111:8968-8972.
153. Castro G.D., Stamato C.J., Castro J.A. 5-Methylcytosine attack by free radicals arising from bromotrichloromethane in a model system: Structures of reaction products. Free Radic. Biol. Med. 1994, 17:419-428.
154. Castro G.D., Díaz Gómez M.I., Castro J.A. 5-Methylcytosine attack by hydroxyl free radicals and during carbon tetrachloride promoted liver microsomal lipid peroxidation: Structure of reaction products. Chem.-Biol. Interact. 1996, 99:289-299.
155. Murata-Kamiya N., Kamiya H., Karino N., Ueno Y., Kaji H., Matsuda A., Kasai H. Formation of 5-formyl-2'-deoxycytidine from 5-methyl-2'-deoxycytidine in duplex DNA by Fenton-type reactions and γ-irradiation. Nucleic Acids Res. 1999, 27:4385-4390.
156. Burdzy A., Noyes K.T., Valinluck V., Sowers L.C. Synthesis of stable-isotope enriched 5-methylpyrimidines and their use as probes of base reactivity in DNA. Nucleic Acids Res. 2002, 30:4068-4074.
157. Cao H., Wang Y. Quantification of oxidative single-base and intrastrand cross-link lesions in unmethylated and CpG-methylated DNA induced by Fenton-type reagents. Nucleic Acids Res. 2007, 35:4833-4844.
158. Shao J., Huang C.-H., Kalyanaraman B., Zhu B.-Z. Potent methyl oxidation of 5-methyl-2'-deoxycytidine by halogenated quinoid carcinogens and hydrogen peroxide via a metal-independent mechanism. Free Radic. Biol. Med. 2013, 60:177-182.
159. Bienvenu C., Wagner J.R., Cadet J. Photosensitized oxidation of 5-methyl-2'-deoxycytidine by 2-methyl-1,4-naphthoquinone - characterization of 5-(hydroperoxymethyl)-2'-deoxycytidine and stable methyl group oxidation products. J. Am. Chem. Soc. 1996, 118:11406-11411.
160. Zhang Q., Wang Y. Independent generation of 5-(2'-deoxycytidinyl)methyl radical and the formation of a novel cross-link lesion between 5-methylcytosine and guanine. J. Am. Chem. Soc. 2003, 125:12795-12802.
161. Zhang Q.Q., Wang Y. Generation of 5-(2'-deoxycytidyl)methyl radical and the formation of intrastrand cross-link lesions in oligodeoxyribonucleotides. Nucleic Acids Res. 2005, 33:1593-1603.
162. Prado F.M., Oliveira M.C.B., Miyamoto S., Martinez G.R., Medeiros M.H.G., Ronsein G.E., Di Mascio P. Thymine hydroperoxide as a potential source of singlet molecular oxygen in DNA. Free Radic. Biol. Med. 2009, 47:401-409.
163. Yamada H., Tanabe K., Ito T., Nishimoto S.I. The pH effect on the naphthoquinone-photosensitized oxidation of 5-methylcytosine. Chem. Eur. J. 2008, 14:10453-10461.
164. Kanvah S., Schuster G.B. One-electron oxidation of DNA: the effect of replacement of cytosine with 5-methylcytosine on long-distance radical cation transport and reaction. J. Am. Chem. Soc. 2004, 126:7341-7344.
165. Privat E., Sowers L.C. Photochemical deamination and demethylation of 5-methylcytosine. Chem. Res. Toxicol. 1996, 9:745-750.
166. Bienvenu C., Cadet J. Synthesis and kinetic study of the deamination of the cis diastereomers of 5,5-dihydroxy-5,6-dihydro-5-methyl-2'-deoxycytidine. J. Org. Chem. 1996, 61:2632-2637.
167. Bienvenu C., Lebrun C., Cadet J. Photo-sensitized formation of the cis-(5R,6R) diastereomer of 5,6-dihydroxy-5,6-dihydro-5-methyl-2'-deoxycytidine. J. Chim. Phys. Phys. -Chim. Biol. 1997, 94:300-305.
168. 2/ascorbate-induced formation of 5-methylcytosine glycol at CpG sites in duplex DNA. Nucleic Acids Res. 2009, 37:6635-6643.
169. Lafrançois C.J., Fujimoto J., Sowers L.C. Synthesis and characterization of isotopically enriched pyrimidine deoxynucleoside oxidation damage products. Chem. Res. Toxicol. 1998, 11:75-83.
170. Divakar K.J., Reese C.B. 4-(1,2,4-triazol-1-yl)- And 4-(3-nitro-1,2,4-triazol-1-yl)-1-(β-D-2,3, 5-tri-O-acetylarabinofuranosyl)pyrimidin-2(1H)-ones. Valuable intermediates in the synthesis of derivatives of 1-(β-d-arabinofuranosyl)cytosine (Ara-C). J. Chem. Soc., Perkin Trans. 1982, 1:1171-1176.
171. Herring J.L., Rogstad D.K., Sowers L.C. Enzymatic methylation of DNA in cultured human cells studied by stable isotope incorporation and mass spectrometry. Chem. Res. Toxicol. 2009, 22:1060-1068.
172. Cline R.E., Fink R.M., Fink K. Synthesis of 5-substituted pyrimidines via formaldehyde addition. J. Am. Chem. Soc. 1959, 81:2521-2527.
173. Maley F. Nucleotide interconversions. VI. The enzymic formation of 5-methyluridylic acid. Arch. Biochem. Biophys. 1962, 96:550-556.
174. Abdel-Rahman A.A.H., El Ashry E.S.H. Efficient synthesis of 5-hydroxymethyl pyrimidines and their nucleosides using microwave irradiation. Synlett 2002, 2043-2044.
175. Schiesser S., Hackner B., Pfaffeneder T., Müller M., Hagemeier C., Truss M., Carell T. Mechanism and stem-cell activity of 5-carboxycytosine decarboxylation determined by isotope tracing. Angew. Chem. Int. Ed. 2012, 51:6516-6520.
176. Abdel Rahman A.A.H., Wada T., Saigo K. Facile methods for the synthesis of 5-formylcytidine. Tetrahedron Lett. 2001, 42:1061-1063.
177. Munzel M., Globisch D., Trindler C., Carell T. Efficient synthesis of 5-hydroxymethylcytosine containing DNA. Org. Lett. 2010, 12:5671-5673.
178. Dai Q., Song C.X., Pan T., He C. Syntheses of two 5-hydroxymethyl-2'-deoxycytidine phosphoramidites with TBDMS as the 5-hydroxymethyl protecting group and their incorporation into DNA. J. Org. Chem. 2011, 76:4182-4188.
179. Dai Q., He C. Syntheses of 5-formyl- and 5-carboxyl-dc containing DNA oligos as potential oxidation products of 5-hydroxymethylcytosine in DNA. Org. Lett. 2011, 13:3446-3449.
180. Münzel M., Lischke U., Stathis D., Pfaffeneder T., Gnerlich F.A., Deiml C.A., Koch S.C., Karaghiosoff K., Carell T. Improved synthesis and mutagenicity of oligonucleotides containing 5-hydroxymethylcytosine, 5-formylcytosine and 5-carboxylcytosine. Chem. Eur. J. 2011, 17:13782-13788.
181. Hashimoto H., Hong S., Bhagwat A.S., Zhang X., Cheng X. Excision of 5-hydroxymethyluracil and 5-carboxylcytosine by the thymine DNA glycosylase domain: Its structural basis and implications for active DNA demethylation. Nucleic Acids Res. 2012, 40:10203-10214.
182. Mao W., Hu J., Hong T., Xing X., Wang S., Chen X., Zhou X. A convenient method for selective detection of 5-hydroxymethylcytosine and 5-formylcytosine sites in DNA sequences. Org. Biomol. Chem. 2013, 11:3568-3572.
183. Sugiyama H., Matsuda S., Kino K., Zhang Q.M., Yonei S., Saito I. New synthetic method of 5-formyluracil-containing oligonucleotides and their melting behavior. Tetrahedron Lett. 1996, 37:9067-9070.
184. Karino N., Ueno Y., Matsuda A. Synthesis and properties of oligonucleotides containing 5-formyl-2'-deoxycytidine: In vitro DNA polymerase reactions on DNA templates containing 5-formyl-2'-deoxycytidine. Nucleic Acids Res. 2001, 29:2456-2463.
185. Steigenberger B., Schiesser S., Hackner B., Brandmayr C., Laube S.K., Steinbacher J., Pfaffeneder T., Carell T. Synthesis of 5-hydroxymethyl-, 5-formyl-, and 5-carboxycytidine- triphosphates and their incorporation into oligonucleotides by polymerase chain reaction. Org. Lett. 2013, 15:366-369.
186. Mohamady S., Desoky A., Taylor S.D. Sulfonyl imidazolium salts as reagents for the rapid and efficient synthesis of nucleoside polyphosphates and their conjugates. Org. Lett. 2012, 14:402-405.
187. Nabel C.S., Manning S.A., Kohli R.M. The curious chemical biology of cytosine: Deamination, methylation,and oxidation as modulators of genomic potential. ACS Chem. Biol. 2012, 7:20-30.
188. Shen J.C., Rideout W.M., Jones P.A. The rate of hydrolytic deamination of 5-methylcytosine in double-stranded DNA. Nucleic Acids Res. 1994, 22:972-976.
189. Labet V., Morell C., Cadet J., Eriksson L.A., Grand A. Hydrolytic deamination of 5-methylcytosine in protic medium-A theoretical study. J. Phys. Chem. A 2009, 113:2524-2533.
190. Williams R.T., Wang Y. A density functional theory study on the kinetics and thermodynamics of N-glycosidic bond cleavage in 5-substituted 2'-deoxycytidines. Biochemistry 2012, 51:6458-6462.
191. Inoue A., Zhang Y. Replication-dependent loss of 5-hydroxymethylcytosine in mouse preimplantation embryos. Science 2011, 334:194.
192. Valinluck V., Sowers L.C. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res. 2007, 67:946-950.
193. Schmitz K.M., Petersen-Mahrt S.K. AIDing the immune system-DIAbolic in cancer. Semin. Immunol. 2012, 24:241-245.
194. Popp C., Dean W., Feng S.H., Cokus S.J., Andrews S., Pellegrini M., Jacobsen S.E., Reik W. Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature 2010, 463:1101-U1126.
195. Nabel C.S., Jia H., Ye Y., Shen L., Goldschmidt H.L., Stivers J.T., Zhang Y., Kohli R.M. AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation. Nat. Chem. Biol. 2012, 8:751-758.
196. Hashimoto H., Zhang X., Cheng X. Excision of thymine and 5-hydroxymethyluracil by the MBD4 DNA glycosylase domain: Structural basis and implications for active DNA demethylation. Nucleic Acids Res. 2012, 40:8276-8284.
197. Moréra S., Grin I., Vigouroux A., Couvé S., Henriot V., Saparbaev M., Ishchenko A.A. Biochemical and structural characterization of the glycosylase domain of MBD4 bound to thymine and 5-hydroxymethyuracil-containing DNA. Nucleic Acids Res. 2012, 40:9917-9926.
198. Cortellino S., Xu J., Sannai M., Moore R., Caretti E., Cigliano A., Le Coz M., Devarajan K., Wessels A., Soprano D., Abramowitz L.K., Bartolomei M.S., Rambow F., Bassi M.R., Bruno T., Fanciulli M., Renner C., Klein-Szanto A.J., Matsumoto Y., Kobi D., Davidson I., Alberti C., Larue L., Bellacosa A. Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell 2011, 146:67-79.
199. Hashimoto H., Zhang X., Cheng X. Selective excision of 5-carboxylcytosine by a thymine DNA glycosylase mutant. J. Mol. Biol. 2013, 425:971-976.
200. Shen L., Wu H., Diep D., Yamaguchi S., D'Alessio A.C., Fung H.L., Zhang K., Zhang Y. Genome-wide analysis reveals TET- and TDG-dependent 5-methylcytosine oxidation dynamics. Cell 2013, 153:692-706.
201. Zhang P., Huang B., Xu X., Sessa W.C. Ten-eleven translocation (Tet) and thymine DNA glycosylase (TDG), components of the demethylation pathway, are direct targets of miRNA-29a, Biochem. Biophys. Res. Commun. 2013, 437:368-373.
202. Métivier R., Gallais R., Tiffoche C., Le Péron C., Jurkowska R.Z., Carmouche R.P., Ibberson D., Barath P., Demay F., Reid G., Benes V., Jeltsch A., Gannon F., Salbert G. Cyclical DNA methylation of a transcriptionally active promoter. Nature 2008, 452:45-50.
203. Hamm S., Just G., Lacoste N., Moitessier N., Szyf M., Mamer O. On the mechanism of demethylation of 5-methylcytosine in DNA. Bioorg. Med. Chem. Lett. 2008, 18:1046-1049.
204. Chen C.C., Wang K.Y., Shen C.K.J. The mammalian de novo DNA methyltransferases DNMT3A and DNMT3B are also DNA 5-hydroxymethylcytosine dehydroxymethylases. J. Biol. Chem. 2012, 287:33116-33121.
205. Chen C.C., Wang K.Y., Shen C.K.J. DNA 5-methylcytosine demethylation activities of the mammalian DNA methyltransferases. J. Biol. Chem. 2013, 288:9084-9091.
206. Kamiya H., Tsuchiya H., Karino N., Ueno Y., Matsuda A., Harashima H. Mutagenicity of 5-formylcytosine, an oxidation product of 5-methylcytosine, in DNA in mammalian cells. J. Biochem. 2002, 132:551-555.
207. Yuan B., Wang J., Cao H., Sun R., Wang Y. High-throughput analysis of the mutagenic and cytotoxic properties of DNA lesions by next-generation sequencing. Nucleic Acids Res. 2011, 39:5945-5954.
208. Kellinger M.W., Song C.X., Chong J., Lu X.Y., He C., Wang D. 5-Formylcytosine and 5-carboxylcytosine reduce the rate and substrate specificity of RNA polymerase II transcription. Nat. Struct. Mol. Biol. 2012, 19:831-833.
209. Foltz G., Yoon J.G., Lee H., Ryken T.C., Sibenaller Z., Ehrich M., Hood L., Madan A. DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis. Oncogene 2009, 28:2667-2677.
210. Gaudet F., Hodgson J.G., Eden A., Jackson-Grusby L., Dausman J., Gray J.W., Leonhardt H., Jaenisch R. Induction of tumors in mice by genomic hypomethylation. Science 2003, 300:489-492.
211. Ehrlich M. DNA hypomethylation in cancer cells. Epigenomics 2009, 1:239-259.
212. Hegi M.E., Sciuscio D., Murat A., Levivier M., Stupp R. Epigenetic deregulation of DNA repair and its potential for therapy. Clin. Cancer. Res. 2009, 15:5026-5031.
213. Weller M., Stupp R., Reifenberger G., Brandes A.A., van den Bent M.J., Wick W., Hegi M.E. MGMT promoter methylation in malignant gliomas: ready for personalized medicine?. Nat. Rev. Neurol. 2010, 6:39-51.
214. Liu C., Liu L., Chen X., Shen J., Shan J., Xu Y., Yang Z., Wu L., Xia F., Bie P., Cui Y., Bian X.W., Qian C. Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1. PLoS One 2013, 8:e62828.
215. Gambichler T., Sand M., Skrygan M. Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma. Melanoma Res. 2013, 23:218-220.
216. Yang H., Liu Y., Bai F., Zhang J.Y., Ma S.H., Liu J., Xu Z.D., Zhu H.G., Ling Z.Q., Ye D., Guan K.L., Xiong Y. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 2013, 32:663-669.
217. Kudo Y., Tateishi K., Yamamoto K., Yamamoto S., Asaoka Y., Ijichi H., Nagae G., Yoshida H., Aburatani H., Koike K. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci. 2012, 103:670-676.
218. Yang Q., Wu K., Ji M., Jin W., He N., Shi B., Hou P. Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor pronostic factor in gastric cancer patients. J. Biomed. Nanotechnol. 2013, 9:1607-1616.
219. Jin S.G., Jiang Y., Qiu R., Rauch T.A., Wang Y., Schackert G., Krex D., Lu Q., Pfeifer G.P. 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res. 2011, 71:7360-7365.
220. Mason E.F., Hornick J.L. Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis. Mod. Pathol. 2013, [Epub ahead of print]. 10.1038/modpathol.2013.86.
221. Chen M.L., Shen F. Quantification of 5-methylcytosine and 5-hydroxymethylcytosine in genomic DNA from hepatocellular carcinoma tissues by capillary hydrophilic-interaction liquid chromatography/quadrupole time-of-flight mass spectrometry. Clin. Chem. 2013, 59:824-832.
222. Cadieux B., Ching T.T., VandenBerg S.R., Costello J.F. Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Res. 2006, 66:8469-8476.
223. Hervouet E., Debien E., Campion L., Charbord J., Menanteau J., Vallette F.M., Cartron P.F. Folate supplementation limits the aggressiveness of glioma via the remethylation of DNA repeats element and genes governing apoptosis and proliferation. Clin. Cancer. Res. 2009, 15:3519-3529.
224. Mohr F., Döhner K., Buske C., Rawat V.P.S., Genes T.E.T New players in DNA demethylation and important determinants for stemness. Exp. Hematol. 2011, 39:272-281.
225. Langemeijer S.M.C., Aslanyan M.G., Jansen J.H. TET proteins in malignant hematopoiesis. Cell Cycle 2009, 8:4044-4048.
226. Figueroa M.E., Abdel-Wahab O., Lu C., Ward P.S., Patel J., Shih A., Li Y., Bhagwat N., Vasanthakumar A., Fernandez H.F., Tallman M.S., Sun Z., Wolniak K., Peeters J.K., Liu W., Choe S.E., Fantin V.R., Paietta E., Löwenberg B., Licht J.D., Godley L.A., Delwel R., Valk P.J.M., Thompson C.B., Levine R.L., Melnick A. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010, 18:553-567.
227. Moran-Crusio K., Reavie L., Shih A., Abdel-Wahab O., Ndiaye-Lobry D., Lobry C., Figueroa M., Vasanthakumar A., Patel J., Zhao X., Perna F., Pandey S., Madzo J., Song C., Dai Q., He C., Ibrahim S., Beran M., Zavadil J., Nimer S., Melnick A., Godley L., Aifantis I., Levine R. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 2011, 20:11-24.
228. Quivoron C., Couronné L., Della Valle V., Lopez C., Plo I., Wagner-Ballon O., Do Cruzeiro M., Delhommeau F., Arnulf B., Stern M.H., Godley L., Opolon P., Tilly H., Solary E., Duffourd Y., Dessen P., Merle-Beral H., Nguyen-Khac F., Fontenay M., Vainchenker W., Bastard C., Mercher T., Bernard O. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 2011, 20:25-38.
229. Shibata T., Kokubu A., Miyamoto M., Sasajima Y., Yamazaki N. Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation. Am. J. Pathol. 2011, 178:1395-1402.
230. Liu Y., Jiang W., Liu J., Zhao S., Xiong J., Mao Y., Wang Y. IDH1 mutations inhibit multiple α-ketoglutarate-dependent dioxygenase activities in astroglioma. J. Neurooncol. 2012, 109:253-260.
231. Wang P., Dong Q., Zhang C., Kuan P.F., Liu Y., Jeck W.R., Andersen J.B., Jiang W., Savich G.L., Tan T.X., Auman J.T., Hoskins J.M., Misher A.D., Moser C.D., Yourstone S.M., Kim J.W., Cibulskis K., Getz G., Hunt H.V., Thorgeirsson S.S., Roberts L.R., Ye D., Guan K.L., Xiong Y., Qin L.X., Chiang D.Y. Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene 2013, 32:3091-3100.
232. Pfeifer G.P., Kadam S., Jin S.G. 5-hydroxymethylcytosine and its potential roles in development and cancer. Epigenetics Chromatin 2013, 6:10.
233. Patel J.P., Gönen M., Figueroa M.E., Fernandez H., Sun Z., Racevskis J., Van Vlierberghe P., Dolgalev I., Thomas S., Aminova O., Huberman K., Cheng J., Viale A., Socci N.D., Heguy A., Cherry A., Vance G., Higgins R.R., Ketterling R.P., Gallagher R.E., Litzow M., Van Den Brink M.R.M., Lazarus H.M., Rowe J.M., Luger S., Ferrando A., Paietta E., Tallman M.S., Melnick A., Abdel-Wahab O., Levine R.L. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N. Engl. J. Med. 2012, 366:1079-1089.
234. Huang H., Jiang X., Li Z., Li Y., Song C.X., He C., Sun M., Chen P., Gurbuxani S., Wang J., Hong G.M., Elkahloun A.G., Arnovitz S., Szulwach K., Lin L., Street C., Wunderlich M., Dawlaty M., Neilly M.B., Jaenisch R., Yang F.C., Mulloy J.C., Jin P., Liu P.P., Rowley J.D., Xu M., Chen J. TET1 plays an essential oncogenic role in MLL-rearranged leukemia. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:11994-11999.
235. Olkhov-Mitsel E., Bapat B. Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers. Cancer Med. 2012, 1:237-260.
236. Fukushige S., Horii A. DNA methylation in cancer: a gene silencing mechanism and the clinical potential of its biomarkers. Tohoku J. Exp. Med. 2013, 229:173-185.
237. Samson-Thibault F., Madugundu G.S., Gao S., Cadet J., Wagner J.R. Profiling cytosine oxidation in DNA by LC-MS/MS. Chem. Res. Toxicol. 2012, 25:1902-1911.